In summary, we explored the relationship between KCTD12 expression and tumor clinical stage, prognosis, mutation, genomic heterogeneity, phosphorylation, and immune infiltration using pan-cancer analysis from a new perspective, providing information to better understand the significance of KCTD12 in multiple tumors. This evidence concerns the gene KCTD12 and neoplasm.